Early research (Phase 1)Study completedNCT01352689What this trial is testingCKD-828(80/2.5mg) Pharmacokinetic Study_2ndWho this might be right forHypertension Chong Kun Dang Pharmaceutical 67
Early research (Phase 1)Looking for participantsNCT06823947What this trial is testingStudy of KK3910 in Healthy Volunteers and Patients With Essential HypertensionWho this might be right forHealthy Volunteers Essential Hypertension Kyowa Kirin Co., Ltd. 144
Early research (Phase 1)Study completedNCT06744127What this trial is testingEvaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fasting ConditionsWho this might be right forEssential Hypertension Boryung Pharmaceutical Co., Ltd 58
Early research (Phase 1)Study completedNCT06501586What this trial is testingStudy of SGB-3908 in Healthy Subjects and Mildly Hypertensive SubjectsWho this might be right forHypertension,Essential Suzhou Sanegene Bio Inc. 40
Early research (Phase 1)Study completedNCT06884085What this trial is testingCompare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227BWho this might be right forPrimary Hypertension Addpharma Inc. 70
Early research (Phase 1)Study completedNCT00991705What this trial is testingEvaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male VolunteersWho this might be right forEssential Hypertension Boryung Pharmaceutical Co., Ltd 28
Early research (Phase 1)Study completedNCT06184269What this trial is testingEvaluate the Pharmacokinetics and the Safety After Administration of "BR1017-1" and Co-administration of "BR1017-1A" and "BR1017-1B"Who this might be right forEssential HypertensionPrimary Hypercholesterolemia Boryung Pharmaceutical Co., Ltd 58
Early research (Phase 1)Study completedNCT01842230What this trial is testingStudy to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipineWho this might be right forEssential HypertensionHyperlipidemia Chong Kun Dang Pharmaceutical 24
Early research (Phase 1)Study completedNCT06744062What this trial is testingEvaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 in Healthy Volunteers Fed ConditionsWho this might be right forEssential Hypertension Boryung Pharmaceutical Co., Ltd 48
Early research (Phase 1)Study completedNCT01246193What this trial is testingCKD-828(80/2.5mg) Pharmacokinetic StudyWho this might be right forHypertension Chong Kun Dang Pharmaceutical 65
Early research (Phase 1)Study completedNCT00937534What this trial is testingStudy to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male VolunteersWho this might be right forEssential Hypertension Boryung Pharmaceutical Co., Ltd 22
Early research (Phase 1)Study completedNCT01340131What this trial is testingCKD-828 (40/5mg) Pharmacokinetic StudyWho this might be right forHypertension Chong Kun Dang Pharmaceutical 68
Not applicableStudy completedNCT01743352What this trial is testingComparison of Ultrafast Echo With EchotrackingWho this might be right forEssential Untreated HypertensionHealthy Volunteers French Cardiology Society 57
Early research (Phase 1)Study completedNCT00991783What this trial is testingEvaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male VolunteersWho this might be right forEssential Hypertension Boryung Pharmaceutical Co., Ltd 14
Early research (Phase 1)Study completedNCT06636877What this trial is testingEvaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy VolunteersWho this might be right forEssential HypertensionType 2 Diabetes Boryung Pharmaceutical Co., Ltd 52
Early research (Phase 1)Study completedNCT01146938What this trial is testingA Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy VolunteersWho this might be right forEssential HypertensionHepatic Impairment Boryung Pharmaceutical Co., Ltd 18
Early research (Phase 1)Study completedNCT05993806What this trial is testingA Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy VolunteersWho this might be right forEssential Hypertension Celltrion 50
Early research (Phase 1)Study completedNCT00938132What this trial is testingA Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male VolunteersWho this might be right forEssential Hypertension Boryung Pharmaceutical Co., Ltd 15
Early research (Phase 1)Study completedNCT06889064What this trial is testingEvaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult VolunteersWho this might be right forEssential Hypertension Boryung Pharmaceutical Co., Ltd 28
Early research (Phase 1)Study completedNCT00938262What this trial is testingEvaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male VolunteersWho this might be right forEssential Hypertension Boryung Pharmaceutical Co., Ltd 24